Pharmaceutical Research Associates Group B.V. — Clinical Trial Site

116 Registered trials

19 Currently recruiting

Organisation

Pharmaceutical Research Associates Group B.V.

Location

Groningen, Netherlands

Identifier

ORG-100006268

Address

Van Swietenlaan 6, 9728 NZ, Netherlands

Departments

#001_00270428: Program Management
Clinical research ICON
Clinical Research Unit Groningen
Early Development Service
Early Clinical Services
Early Development
General
N/A
Phase 1 unit
Program Management
Program Management
Program Menagement

Clinical trials at this site (116)

Search interface

A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s dise… Recruiting

2024-511110-21-00 Parkinson’s Disease 1 2024-09-09
First in human study in healthy volunteers and participants with Parkinsons disease with and without GBA1 mutations. Recruiting

2023-509158-68-00 Parkinson’s disease 1 2024-01-25
A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS Ended

2026-525517-31-00 Not applicable, healthy volunteers 3 2026-05-04
Mass Balance Study of [14C] ABBV-932 in Healthy Male Volunteers Ended

2024-514454-75-00 Healthy Volunteers 3 2026-04-16
A single and multiple ascending dose study of topical ladarixin ophthalmic solution in healthy volunteers Ended

2025-524527-46-00 Ocular inflammatory conditions 1 2026-02-16
A trial to evaluate the absolute bioavailability of cenerimod in healthy male participants Ended

2025-522320-27-00 Not applicable - healthy volunteer trial 3 2025-11-17
A Phase 1, Dose-Escalating, Randomized, Placebo-Controlled, 4-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of COR-1… Ended

2023-508543-42-00 Chronic heart failure 1 2024-01-22
A study to investigate the safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of a single subcutaneous dose of GSK4… Halted

2025-525073-37-00 Autosomal Dominant Polycystic Kidney Disease 3 2026-05-12
A Phase I, open-label, non-randomized study to assess the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of … Ended

2025-524172-29-00 Healthy volunteers 3 2026-03-18
A Study to Track How the Healthy Male Participants Handles the New Oral Drug RO7795081 for Weight Management and Diabetes Ended

2025-524210-28-00 Not Applicable 3 2026-02-17
A study in healthy men to test how BI 1584862 is processed in the body Ended

2025-522311-41-00 Healthy volunteer trial 3 2026-01-22
A study investigating the effect of curcumin on the absorption and elimination of IMU 838, a new compound that may potentially be used in th… Ended

2025-523791-24-00 Multiple sclerosis 3 2026-01-08
A study to compare how the body absorbs different formulations of a new medicine, and how food affects drug absorption, in healthy participa… Ended

2025-523430-14-00 Psoriasis 3 2025-12-24
A study investigating the safety of RO7795074, a new compound that may potentially be used in the treatment of type 1 diabetes, and the effe… Ended

2025-521921-34-00 Overweight or Obese (otherwise healthy) 3 2025-12-19
A study in healthy men and women to test how BI 3000202 is taken up and processed by the body Ended

2023-510345-21-00 Healthy volunteer trial 3 2025-12-16
A Study Investigating the Safety and Absorption of Different Administration forms of RO7795074, a New Compound that may Potentially be Used … Ended

2025-521888-13-00 Overweight or Obese (otherwise healthy) 3 2025-12-02
A Phase 1, Multi-Cohort, Open-Label, Randomized Pilot Study to Evaluate the Effect of Food and a Proton-Pump Inhibitor (esomeprazole) on the… Ended

2025-523370-16-00 Parkinsonian syndromes 3 2025-11-17
A study investigating the safety, absorption, and elimination of RO7795081, a new compound that may potentially be used in the treatment of … Ended

2025-522766-78-00 Not Applicable 3 2025-11-10
Phase 1 Study to Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Men Participants Ended

2025-521402-18-00 Desmoid tumor 3 2025-10-24
A study investigating the safety, absorption, and elimination of NT 0150, a new compound that may potentially be used in the treatment of br… Ended

2024-520142-32-00 Cryopyrin associated periodic syndrome 1 2025-09-08
A study comparing different RO7269162 capsules and investigating the effect of food on the uptake, breakdown, and elimination of RO7269162 i… Ended

2025-520616-33-00 Not Applicable 3 2025-09-02
A Phase 1, Single-Center, Open-Label, Fixed-Sequence, 2-Part Study to Assess the Pharmacokinetics of IMU-838 Administered Alone and in Combi… Ended

2025-521754-41-00 Multiple sclerosis 3 2025-08-15
A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants Ended

2024-518696-65-00 (HR) -positive human epidermal growth factor receptor 2 3 2025-08-12
A study to learn how the study medicine called [14C]PF-07054894 is processed by the body. Ended

2024-519882-23-00 Inflammatory bowel disease. 3 2025-06-13